Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
34.5%
% of FMED's 65 holdings also in PINK
37.7%
% of PINK's 56 holdings also in FMED
Overlap by Weight
Sector Drift (FMED minus PINK)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FMED |
Weight in PINK |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 4.7% | 5.4% | 4.7% |
|
BOSTON SCIENTIFIC CORP | 5.6% | 4.2% | 4.2% |
|
INTUITIVE SURGICAL INC | 3.8% | 4.8% | 3.8% |
|
REGENERON PHARMACEUTICALS | 3.8% | 4.8% | 3.8% |
|
ELI LILLY & CO | 2.3% | 6.5% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
FMED Overweight Relative to PINK
|
ALNYLAM PHARMACEUTICALS INC | 4.4% |
|
DANAHER CORP | 3.7% |
|
INSULET CORP | 3.4% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 3.0% |
 |
ARGENX SE ADR | 2.3% |
|
UCB SA | 2.3% |
|
STRYKER CORP | 2.2% |
|
PENUMBRA, INC. | 2.1% |
|
EXACT SCIENCES CORP | 2.0% |
|
LIFESTANCE HEALTH GROUP, INC. | 2.0% |
FMED Underweight Relative to PINK
|
SAREPTA THERAPEUTICS INC | -9.2% |
|
PURECYCLE TECHNOLOGIES INC | -5.8% |
 |
SANOFI-AVENTIS-ADR | -5.0% |
|
ELI LILLY & CO | -4.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | -3.5% |
|
GILEAD SCIENCES INC | -3.1% |
|
3M CO | -3.1% |
|
JOHNSON & JOHNSON | -2.7% |
|
NEUROCRINE BIOSCIENCES INC | -2.3% |
|
MERCK & CO. INC. | -2.2% |